» Articles » PMID: 39079813

Pre-existing Immunity to Influenza Aids Ferrets in Developing Stronger and Broader H3 Vaccine-induced Antibody Responses

Overview
Journal Vaccine
Date 2024 Jul 30
PMID 39079813
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza seasons occur annually, building immune history for individuals, but the influence of this history on subsequent influenza vaccine protection remains unclear. We extracted data from an animal trial to study its potential impact. The trial involved 80 ferrets, each receiving either one type of infection or a placebo before vaccination. We quantified the vaccine protection by evaluating hemagglutination inhibition (HAI) antibody titer responses. We tested whether hosts with different infection histories exhibited similar level of responses when receiving the same vaccine for all homologous and heterologous outcomes. We observed that different pre-existing immunities were generally beneficial to vaccine induced responses, but varied in magnitude. Without pre-immunity, post-vaccination HAI titers after the 1st dose of the vaccine were less likely to be above 1:40, and a booster shot was needed. Our study suggests that pre-existing immunity may strengthen and extend the homologous and heterologous vaccine responses.

Citing Articles

Exploring bias due to below-limit-of-detection values in influenza vaccine antibody modeling: A case study and instructional guide for the CIVIC study.

Ge Y, Handel A, Giabbanelli P, Lemacks J, Greer T, Raynee P Vaccine. 2025; 49:126802.

PMID: 39908720 PMC: 11875013. DOI: 10.1016/j.vaccine.2025.126802.

References
1.
FRANCIS Jr T . Influenza: the new acquayantance. Ann Intern Med. 1953; 39(2):203-21. DOI: 10.7326/0003-4819-39-2-203. View

2.
Bergstrom J, Xu H, Heyman B . Epitope-Specific Suppression of IgG Responses by Passively Administered Specific IgG: Evidence of Epitope Masking. Front Immunol. 2017; 8:238. PMC: 5337509. DOI: 10.3389/fimmu.2017.00238. View

3.
Ohmit S, Petrie J, Cross R, Johnson E, Monto A . Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis. 2011; 204(12):1879-85. DOI: 10.1093/infdis/jir661. View

4.
Grohskopf L, Ferdinands J, Blanton L, Broder K, Loehr J . Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season. MMWR Recomm Rep. 2024; 73(5):1-25. PMC: 11501009. DOI: 10.15585/mmwr.rr7305a1. View

5.
Iuliano A, Roguski K, Chang H, Muscatello D, Palekar R, Tempia S . Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2017; 391(10127):1285-1300. PMC: 5935243. DOI: 10.1016/S0140-6736(17)33293-2. View